The Methodology
Transparent, context-aware scoring. How we source data, apply real-world context, calculate scores, and disclose limitations when data is incomplete.
How HumanSafe™ Scoring Works
HumanSafe™ evaluates products across four independent dimensions. Each score uses different data sources, methodologies, and weightings. This page documents our complete approach—what we measure, how we calculate it, and where we get our data.
The Four Independent Scores
🛡️ HSS - Human Safety
Letter Grade (A+ to F)
Health risk assessment
🌍 ESS - Environmental
Numerical (1.0–10.0)
Environmental impact
📖 CTS - Transparency
Numerical (1.0–10.0)
Information disclosure
⭐ CES - Experience
Numerical (1.0–10.0)
Real-world performance
HSS - Human Safety Score
Letter Grade: A+ (9.0–10.0) to F (<4.0)
Context-aware health risk assessment considering toxicology, concentration, exposure route,
duration, and target population.
Multi-Layer Assessment Framework
HumanSafe™ uses a sophisticated multi-layer system that evaluates ingredients through multiple gates before arriving at a final score. Each layer refines the assessment based on scientific principles:
Layer 1: Base Toxicity
Intrinsic hazard profile from peer-reviewed toxicology data. Evaluates acute toxicity, chronic toxicity, skin safety, organ toxicity, carcinogenicity, and regulatory status.
Layer 2: Molecular Penetration
The 500 Dalton Rule: Molecules above ~500 Da generally cannot penetrate intact skin. Large molecules receive modified assessment focused on surface interactions only.
Layer 3: Product Type
Rinse-off, leave-on, spray, mucous membrane, and oral products have different risk profiles. Factor weightings adjust based on exposure duration and absorption pathway.
Layer 4: Population & Context
Adults, children, babies, pregnancy each have different safety thresholds. Compromised skin, medical conditions, and concurrent exposures further refine assessment.
The Seven Core Risk Factors
Each ingredient is evaluated across seven independent risk dimensions. The relative importance (weighting) of each factor varies based on molecular size and application type:
| Factor | What We Evaluate | Weighting Approach |
|---|---|---|
| F1: Acute Toxicity | Immediate harm potential based on LD50/LC50 data from animal and in-vitro studies | Higher weight for rinse-off products where accidental ingestion is possible |
| F2: Chronic Toxicity | Long-term repeated exposure effects, cumulative organ damage, systemic impacts | Higher weight for leave-on products with daily use patterns |
| F3: Skin Safety | Irritation potential, sensitization (allergic) reactions, dermal absorption, barrier damage | Highest weight for all dermal products; primary concern for large molecules |
| F4: Organ/System Toxicity | Effects on liver, kidneys, nervous system, endocrine disruption, reproductive health | Higher weight for penetrating molecules (<500 Da); reduced for non-penetrating molecules |
| F5: Carcinogenicity | Cancer risk based on IARC, NTP, and EPA classifications; mutagenicity data | Weight adjusted based on exposure frequency and cumulative dose potential |
| F6: Regulatory Approval | FDA, EU Cosmetics Regulation, Health Canada, REACH, and international clearances | Consistent baseline weight; serves as safety net for data-limited ingredients |
| F7: Data Quality | Strength, reliability, and completeness of available safety data (peer-reviewed studies preferred) | Acts as confidence modifier; incomplete data lowers final score |
Molecular Weight Penetration Logic
Before applying factor weights, we determine if the ingredient can penetrate the skin barrier:
<500 Daltons
Skin Permeable
Can penetrate intact skin barrier and reach systemic circulation. Full 7-factor assessment
with systemic toxicity factors at standard weights.
500–1000 Daltons
Limited Penetration
Borderline permeability, especially with penetration enhancers or compromised skin.
Modified assessment with reduced systemic weights.
>1000 Daltons
Non-Penetrating
Cannot penetrate intact skin; surface interaction only. Assessment focuses primarily on
F3 (skin safety) with systemic factors de-emphasized.
Example: Why Molecular Size Matters
Ingredient A (Ethanol, 46 Da): Small molecule, full skin penetration. Evaluated across all 7 factors because it can reach bloodstream and affect internal organs.
Ingredient B (High MW Hyaluronic Acid, >1000 Da): Large molecule, cannot penetrate intact skin. Assessment emphasizes surface irritation and allergic potential only—systemic factors receive minimal weight because ingredient stays on skin surface.
Product Type Application Modifiers
Factor weights adjust based on how the product is used. The same ingredient at the same concentration will have different risk profiles depending on application type:
- Rinse-Off Products: Brief contact time reduces exposure. Acute toxicity weighted higher due to ingestion risk.
- Leave-On Products: Extended contact increases cumulative exposure. Chronic toxicity and sensitization weighted higher.
- Spray/Aerosol Products: Inhalation pathway introduces respiratory concerns. Lung toxicity considerations added.
- Mucous Membrane Products: Higher absorption rates require stricter thresholds across all factors.
- Oral/Ingestion Products: Direct systemic absorption. Organ toxicity and carcinogenicity weighted most heavily.
Confidence Score Integration
Every assessment includes a confidence score that reflects data quality and completeness:
High Confidence (Score: 8.5–10.0)
- Multiple peer-reviewed studies
- Long history of safe use
- Complete toxicity profile
- Regulatory approval in major markets
Low Confidence (Score: 1.0–5.0)
- Limited safety data
- New ingredient with short market history
- Data gaps in critical endpoints
- Conflicting research findings
When confidence is low, final scores are adjusted downward. This precautionary approach protects consumers when scientific certainty is insufficient.
Letter Grade Ranges
| Grade | Range | Classification | Typical Meaning |
|---|---|---|---|
| A+ | 9.0–10.0 | Elite Biocompatibility | Exceptionally safe, minimal concerns |
| A | 8.0–8.9 | High Safety Integrity | Very safe, reliable profile |
| A- | 7.0–7.9 | Functional Safety | Generally safe for intended use |
| B | 6.0–6.9 | Exposure-Conditional | Safe under specific limits |
| C | 5.0–5.9 | Toxicological Alert (L1) | Notable data gaps or sensitivities |
| D | 4.0–4.9 | High Toxicological Risk | Elevated risk potential |
| F | < 4.0 | Biocompatibility Breach | Severe safety failure |
ESS - Environmental Score
Numerical: 1.0–10.0 (10 = best for environment)
Lifecycle environmental impact from raw material sourcing through disposal. Evaluates biodegradability,
aquatic toxicity, bioaccumulation, and manufacturing footprint.
The Five Environmental Factors (Weighted)
| Factor | Weight | What We Evaluate |
|---|---|---|
| Biodegradability | 30% | How quickly and completely the ingredient breaks down in the environment (OECD tests) |
| Aquatic Toxicity | 30% | Harm to aquatic organisms: algae, daphnia (water fleas), and fish (LC50/EC50 data) |
| Bioaccumulation | 20% | Tendency to accumulate in organisms and food chains (BCF/log Kow values) |
| Manufacturing Impact | 15% | Energy, water usage, emissions, and waste in production |
| End-of-Life | 5% | Packaging recyclability, disposal impacts, circular economy potential |
Score Ranges
- 9.0–10.0: Readily biodegradable, minimal aquatic toxicity, sustainable sourcing
- 7.0–8.9: Good environmental profile with minor concerns
- 5.0–6.9: Moderate impact, some persistence or toxicity
- 3.0–4.9: Significant environmental concerns, poor biodegradability
- 1.0–2.9: High environmental risk, persistent, bioaccumulative
CTS - Company Transparency Score
Numerical: 1.0–10.0 (10 = complete transparency)
How openly the company shares ingredient data, concentrations, sourcing information, and
testing data beyond regulatory minimums.
The Five Transparency Criteria
| Criterion | Weight | What We Evaluate |
|---|---|---|
| Ingredient Disclosure | 35% | Complete INCI names + concentration ranges or exact percentages |
| Sourcing Information | 25% | Supply chain transparency, origin of raw materials, supplier ethics |
| Manufacturing Process | 15% | Production methods, quality control, facility information |
| Testing & Studies | 15% | Clinical studies, safety testing data, third-party verification |
| Responsiveness | 10% | How quickly and completely the company answers questions |
What Lowers CTS
- Hiding behind "proprietary formula" claims
- Refusing to disclose concentrations
- Vague ingredient listings ("fragrance," "natural flavors")
- No response to information requests
- Inconsistent labeling across markets
CES - Customer Experience Score
Numerical: 1.0–10.0 (10 = excellent experience)
Real-world performance and user satisfaction based on verified customer feedback.
Does the product actually work as claimed?
The Five Experience Factors
| Factor | Weight | What We Evaluate |
|---|---|---|
| Verified Reviews | 40% | Aggregate rating from verified purchaser reviews across platforms |
| Claim Validation | 25% | Does the product deliver on its marketing promises? |
| Sensory Experience | 15% | Texture, scent, feel, ease of use (subjective but aggregated) |
| Value for Cost | 10% | Performance relative to price point |
| Customer Service | 10% | Company responsiveness, returns policy, support quality |
Context Adjustments
The same ingredient at the same concentration can have vastly different risk profiles depending on how it's used. We adjust base scores for real-world context.
Four Context Factors
1. Product Type
- Rinse-off products: Lower exposure (shampoo, cleanser)
- Leave-on products: Higher exposure (lotion, serum)
- Spray products: Inhalation risk (aerosols, mists)
- Mucous membrane products: Higher absorption (lip balm, eye cream)
2. Concentration
- 0.001%: Trace/incidental (minimal risk)
- 0.1%: Low concentration
- 1%: Moderate concentration
- 10%+: High concentration (active ingredient level)
3. Exposure Route
- Dermal: Skin application (most common)
- Inhalation: Breathing (sprays, powders)
- Ingestion: Oral products (toothpaste, lip products)
- Ocular: Eye area (mascara, eye cream)
4. Target Population
- Adults: Standard safety thresholds
- Children: Lower tolerance, higher standards
- Babies: Much stricter limits
- Pregnancy: Additional reproductive/developmental considerations
Example: Preservative in Different Contexts
Ingredient: Phenoxyethanol at 0.5%
Rinse-off shampoo (Adult): Score A — Brief contact, washes away quickly, low systemic exposure.
Leave-on face cream (Adult): Score A- — Extended contact on facial skin, moderate absorption potential.
Baby lotion (Infant): Score B — Higher safety standards for infants, extended exposure, larger surface area relative to body weight.
Data Sources
We rely on peer-reviewed science, regulatory databases, and established toxicology resources. Our assessments are only as good as the data available.
Primary Data Sources
🔬 Scientific Literature
- PubMed / MEDLINE
- Peer-reviewed toxicology journals
- Clinical studies
- OECD test guidelines
🏛️ Regulatory Databases
- FDA GRAS list
- EU Cosmetics Regulation (CosIng)
- Health Canada Cosmetic Ingredient Hotlist
- EPA TSCA Chemical Substance Inventory
🧪 Toxicology Resources
- IARC Monographs (carcinogenicity)
- NTP (National Toxicology Program)
- ATSDR ToxProfiles
- SCCS opinions (EU Scientific Committee)
🌍 Environmental Data
- ECHA (European Chemicals Agency)
- OECD biodegradation studies
- EPA ECOTOX database
- ISO 14040 lifecycle assessments
What Our Scores Don't Cover
No scoring system is perfect. Here are the explicit limitations of our methodology:
✗ Individual Variation
Scores reflect population-level safety. Your personal response may differ due to genetics, allergies, skin conditions, or medication interactions.
✗ Long-Term Effects
Many ingredients lack 20+ year longitudinal studies. We can't predict effects that might appear decades from now.
✗ Synergistic Interactions
We assess ingredients individually and in formulation context, but complex multi-ingredient interactions are difficult to predict.
✗ Emerging Research
Science evolves. What's considered safe today may be questioned tomorrow as new research emerges.
✗ Proprietary Formulas
When companies hide concentrations, we must estimate—reducing accuracy. Transparency enables better assessment.
✗ Subjective Experience
CES (experience) scores rely on aggregated reviews, which can be manipulated or biased despite verification efforts.
Use Scores as One Input Among Many
HumanSafe™ scores should inform your decisions—not replace your judgment, your doctor's advice, or your personal experience. Discontinue use if you experience adverse reactions, regardless of scores.
Version History
We update our methodology as science evolves. All changes are documented transparently.
| Version | Date | Changes |
|---|---|---|
| v2.0 | January 2026 | Major methodology update: Added multi-layer assessment framework (4 layers), molecular penetration logic (500 Dalton Rule), confidence scoring system, and product type modifiers. Changed HSS from numerical to letter grades. Expanded conceptual explanations while protecting proprietary weighting formulas. |
| v1.5 | September 2025 | Added context adjustments for target population (adults, children, babies, pregnancy). Refined weighting of chronic toxicity factor. Enhanced data quality assessment criteria. |
| v1.0 | March 2021 | Initial methodology release. Established four-score system (HSS, ESS, CTS, CES) with documented weighting and data sources. Foundation for risk-based assessment. |
Related Pages
Learn more about how we apply this methodology in practice.
🏷️ Understanding Your Score
Consumer-friendly guide to reading and interpreting HumanSafe™ scores and badges.
Learn to Read Scores✓ Verification Process
How brands get verified—the operational steps from application to publication.
See the Process📖 About HumanSafe™
Our mission, approach, and why we built HumanSafe™ differently from existing systems.
About UsVersion 2.0 | January 2026 | Document ID: HSMETH-PUB-2026-01